A Multi-Centre, Single-Blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Duac Gel (A Gel containing Clindamycin Phosphate [Equivalent to 1% Clindamycin] and 5% Benzoyl Peroxide) and Differin Gel (A Gel containing 0.1% Adapalene) in the Topical Treatment of Mild to Moderate Acne Vulgaris.

Registry ID

EUCTR2004-002272-41

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

Stiefel Laboratories International Division

Start date

2004-12-07

Completion date

2005-08-09

Last update

2026-08-16

Conditions

• Acne Vulgaris

Summary

The objectives of this clinical trial are to compare the efficacy and safety of Duac Gel Once Daily (a gel formulation containing a combination of clindamycin phosphate [equivalent to 1% clindamycin] and 5% benzoyl peroxide), with Differin Gel (a gel containing 0.1% adapalene) once daily, in the treatment of acne vulgaris of mild to moderate severity.

Locations

• , , UK

Related clinical trials

• Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
• Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of Color Patients
• Weekly Isotretinoin vs Tetracycline for Moderate Acne
• Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.
• Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris
• Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study

View on source registry